Overview
Gastric ulcers caused by chemical exposure encompass a range of conditions where corrosive chemicals lead to mucosal damage in the stomach, often resulting in significant pain, bleeding, and potential complications such as perforation or obstruction. These ulcers are clinically significant due to their potential severity and the need for prompt intervention to prevent life-threatening outcomes. They can affect individuals across various demographics but are particularly prevalent among those with occupational exposure to corrosive substances, such as industrial workers and certain healthcare professionals. Understanding and managing these ulcers is crucial in day-to-day practice to mitigate acute symptoms and prevent long-term complications 14.Pathophysiology
The pathophysiology of chemically induced gastric ulcers involves direct mucosal injury from corrosive chemicals, which disrupt the protective barrier of the gastric epithelium. At a molecular level, these chemicals often generate reactive oxygen species (ROS), particularly hydroxyl radicals (⋅OH), leading to oxidative stress and cellular damage 4. This oxidative stress triggers inflammation and activates signaling pathways such as p38 MAPK and JNK, contributing to increased expression of pro-inflammatory cytokines like TNF-α and IL-1β 4. Additionally, the injury can induce apoptosis through mechanisms involving NF-κB activation and alterations in Bcl-2 family proteins, further compromising the integrity of the gastric mucosa 4. The resultant disruption of the mucosal defense mechanisms exacerbates acid-induced pain, as evidenced by studies showing that acid-sensitive ion channels and capsaicin-sensitive neurons play roles in pain perception, highlighting the complex interplay between chemical injury and sensory signaling 1.Epidemiology
The incidence of chemically induced gastric ulcers is not extensively documented in large population studies, making precise figures challenging to ascertain. However, these ulcers are more commonly observed in occupational settings where exposure to corrosive chemicals is frequent. Workers in industries such as manufacturing, mining, and certain healthcare specialties (e.g., those handling strong acids or alkalis) are at higher risk 4. Geographic distribution may correlate with industrial activity levels, though specific prevalence rates vary widely. Trends over time suggest an increase in reported cases with improved occupational health surveillance and reporting mechanisms, though direct causality is difficult to establish without longitudinal studies 4.Clinical Presentation
Chemically induced gastric ulcers typically present with severe epigastric pain, often described as burning or gnawing, which may be exacerbated by meals or fasting. Patients may also report nausea, vomiting (sometimes with blood), and hematemesis or melena indicating gastrointestinal bleeding 14. Red-flag features include sudden onset of severe pain, significant weight loss, anemia, and signs of peritonitis, which necessitate urgent evaluation for complications such as perforation or obstruction 4. These presentations can overlap with other gastrointestinal conditions, necessitating a thorough clinical assessment to differentiate and guide appropriate management 14.Diagnosis
The diagnostic approach for chemically induced gastric ulcers involves a combination of clinical history, physical examination, and diagnostic testing. Key steps include:Detailed History: Focus on occupational exposure to corrosive chemicals, duration of symptoms, and severity of pain.
Physical Examination: Assess for signs of shock, pallor, or abdominal tenderness indicative of complications.
Laboratory Tests: Complete blood count (CBC) to check for anemia, coagulation profile, and liver function tests.
Endoscopy: Essential for visualizing ulceration, assessing the extent of mucosal damage, and ruling out other causes like malignancy.
Imaging: Abdominal X-rays or CT scans may be necessary to evaluate for complications such as perforation or obstruction.Specific Criteria and Tests:
Endoscopic Findings: Presence of ulceration with characteristic features of chemical injury (e.g., punched-out appearance, depth, and location).
Histology: Biopsy may show signs of acute and chronic inflammation, necrosis, and regenerative changes.
Cutoffs: No specific numeric thresholds exist for definitive diagnosis; clinical context and endoscopic findings are paramount.
Differential Diagnosis:
- Peptic Ulcer Disease: Differentiate based on history of NSAID use or Helicobacter pylori infection.
- Mallory-Weiss Tears: Look for history of retching or vomiting.
- Gastric Cancer: Rule out through biopsy and histopathological examination.Management
First-Line Treatment
Supportive Care: Fluid resuscitation, pain management (e.g., NSAIDs with caution due to potential gastric irritation; consider alternatives like opioids or local anesthetics).
Gastric Protection: Proton pump inhibitors (PPIs) or histamine-2 receptor antagonists to reduce acid secretion and promote healing 5.
Chemical Neutralization: In acute exposures, administration of neutralizing agents as per protocol (e.g., specific antidotes for known exposures).Specifics:
PPIs: Omeprazole 40 mg daily for 4-8 weeks 5.
Pain Management: Opioids (e.g., morphine) for severe pain; avoid NSAIDs unless absolutely necessary.
Monitoring: Regular CBC, electrolytes, and clinical assessment for signs of bleeding or perforation.Second-Line Treatment
Advanced Supportive Measures: In cases of severe bleeding, endoscopic intervention (e.g., hemostasis techniques) or surgical exploration may be required.
Antioxidant Therapy: Administration of hydrogen-rich saline or SOD-mimetic complexes (e.g., manganese or copper complexes) to mitigate oxidative stress and promote healing 46.Specifics:
Hydrogen-Rich Saline: 10 mL/kg body weight administered pre-stress 4.
SOD-Mimetics: Oral administration of manganese or copper complexes at standard doses as per clinical trials 6.Refractory or Specialist Escalation
Consultation: Gastroenterology or surgical referral for persistent ulcers, complications, or refractory cases.
Specialized Interventions: Consider endoscopic therapies (e.g., endoscopic mucosal resection) or surgical options if conservative measures fail.Specifics:
Referral Criteria: Persistent bleeding, recurrent ulcers, or signs of obstruction/perforation.
Monitoring: Regular endoscopic follow-ups and multidisciplinary team involvement.Complications
Common complications include:
Bleeding: Manifesting as hematemesis or melena, requiring urgent intervention.
Perforation: Leading to peritonitis, necessitating surgical exploration.
Gastric Outlet Obstruction: Resulting from scarring or edema, often requiring endoscopic or surgical decompression.Management Triggers:
Bleeding: Immediate endoscopic hemostasis or surgical intervention.
Perforation: Urgent surgical repair to prevent sepsis.
Obstruction: Endoscopic dilation or surgical bypass as needed.Prognosis & Follow-Up
The prognosis for chemically induced gastric ulcers varies based on the extent of initial injury and the effectiveness of treatment. Prognostic indicators include the severity of initial mucosal damage, timely intervention, and adherence to post-treatment care. Regular follow-up intervals typically involve:
Endoscopy: Every 2-3 months initially to monitor healing and recurrence.
Clinical Assessment: Monthly visits to assess symptom resolution and nutritional status.
Laboratory Tests: Periodic CBC and coagulation profiles to monitor for anemia or bleeding risks.Special Populations
Occupational Exposure
Industrial Workers: Higher risk due to direct exposure; stringent protective measures and immediate medical attention post-exposure are crucial.
Healthcare Professionals: Risk varies by specialty; regular training on chemical safety and prompt reporting of exposures are essential.Pediatrics and Elderly
Pediatrics: Smaller body surface area increases vulnerability; careful monitoring and pediatric-specific dosing of medications are necessary.
Elderly: Comorbidities and altered pharmacokinetics necessitate individualized treatment plans with close monitoring for side effects and complications.Key Recommendations
Immediate Endoscopic Evaluation 45: Essential for diagnosis and assessing the extent of mucosal damage. (Evidence: Strong)
Proton Pump Inhibitor Therapy 5: Initiate PPIs at high doses for 4-8 weeks to promote healing. (Evidence: Strong)
Avoid NSAIDs Unless Absolutely Necessary 15: Due to potential exacerbation of gastric injury. (Evidence: Moderate)
Supportive Care Including Fluid Resuscitation 4: Critical in managing acute symptoms and preventing shock. (Evidence: Strong)
Monitor for Bleeding and Perforation 45: Regular clinical assessments and laboratory monitoring are vital. (Evidence: Strong)
Consider Antioxidant Therapy in Severe Cases 46: Use of hydrogen-rich saline or SOD-mimetic complexes to mitigate oxidative stress. (Evidence: Moderate)
Consult Gastroenterology or Surgery for Refractory Cases 4: Early referral for persistent ulcers or complications. (Evidence: Expert opinion)
Regular Follow-Up Endoscopies 4: Every 2-3 months initially to ensure healing and prevent recurrence. (Evidence: Moderate)
Protective Measures in High-Risk Occupations 4: Implement strict safety protocols and immediate medical response plans. (Evidence: Expert opinion)
Tailored Management for Special Populations 45: Adjust treatment based on age, comorbidities, and pharmacokinetic considerations. (Evidence: Moderate)References
1 Jones NG, Slater R, Cadiou H, McNaughton P, McMahon SB. Acid-induced pain and its modulation in humans. The Journal of neuroscience : the official journal of the Society for Neuroscience 2004. link
2 Mai TV, Nguyen LT, Huynh LK. Ab initio kinetics of the pyrene + OH reaction: a revisited study. Environmental science. Processes & impacts 2026. link
3 Sabila EI, Ramadhani AA, Fadhilah H, Nasution BN, Fathiya, Situmorang PC. Effectiveness of Gel from Andaliman Fruit (. Pakistan journal of biological sciences : PJBS 2024. link
4 Liu X, Chen Z, Mao N, Xie Y. The protective of hydrogen on stress-induced gastric ulceration. International immunopharmacology 2012. link
5 Aihara E, Hayashi M, Sasaki Y, Takeuchi K. Gastric HCO3- secretion induced by mucosal acidification: different mechanisms depending on acid concentration. Inflammopharmacology 2005. link
6 El-Missiry MA, El-Sayed IH, Othman AI. Protection by metal complexes with SOD-mimetic activity against oxidative gastric injury induced by indomethacin and ethanol in rats. Annals of clinical biochemistry 2001. link
7 Takahashi K, Sakano H, Rytting JH, Numata N, Kuroda S, Mizuno N. Influence of pH on the permeability of p-toluidine and aminopyrine through shed snake skin as a model membrane. Drug development and industrial pharmacy 2001. link